Table 1.
Fusions with overlap in TCGA HPV-positive cohort
| Fusion name and location | Donor gene | Acceptor gene | # tumors in TCGA (n = 36) | # tumors in JHU (n = 47) |
|---|---|---|---|---|
| chr1~chr1:143743240-145004783 | – | PDE4DIP | 12 | 1 |
| chr4~chr4:184719208-184922478 | – | STOX2 | 6 | 11 |
| chr17~chr17:39743011-39768876 | KRT14 | KRT16 | 6 | 1 |
| chr15~chr15:51329878-51570180 | – | CYP19A1 | 5 | 14 |
| chr3~chr3:100438902-100348442 | TFG | GPR128 | 1 | 3 |
| chr4~chr4:1808661-1741429 | FGFR3 | TACC3 | 1 | 1 |
| chr17~chr17:80797803-80828100 | ZNF750 | TBCD | 1 | 1 |
| chr1~chr1:10753931-9908376 | CASZ1 | CTNNBIP1 | 1 | 1 |
| chr16~chr16:53968021-54685487 | FTO | – | 1 | 1 |
| chr22~chr16:51144580-79639434 | SHANK3 | – | 1 | 1 |
BOLD indicates gene fusion associated with gene expression change. Absent gene names, depicted with a dash, indicate fusion to a non-coding region. Fusion genome positions are based on GRCh37/hg19 assembly.